Back to search

United Kingdom· GB-APID-242011000001103

Half Sinemet CR 25mg/100mg tablets

A medicinal product containing co-careldopa, registered in United Kingdom by Organon Pharma (UK) Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedHalf Sinemet CR 25mg/100mg tabletsATC—REGISTER NO.GB-APID-2420110000011…PACKS LISTED4CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Co-careldopa
Manufacturer
Organon Pharma (UK) Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 4

  • gtin
    5013945002164
  • gtin
    5013945002393
  • gtin
    00191778008692
  • gtin
    00840164517033

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cfa801d0-1c65-48a9-9140-86b65fbe7185
GET /v1/drugs/cfa801d0-1c65-48a9-9140-86b65fbe7185?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "242011000001103",
  "desc": "Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd)",
  "form": "Modified-release tablet",
  "vpid": "39109011000001105",
  "source": "dmd",
  "vtm_id": "775053005",
  "strength": "25 mg",
  "substance": "Co-careldopa",
  "ingredient": "Carbidopa monohydrate",
  "supplier_code": "3146901000001106"
}

See everything about co-careldopa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.